One of a slew of recent initial public offerings (IPOs), telemedicine services provider American Well (NYSE: AMWL), did well on Tuesday. Its shares rose by over 8% on the day, easily eclipsing the gains of the wider stock market.
The catalyst for the latest pop seems to be two updates American Well issued about its IPO, one after market hours on Monday, and the other on Tuesday morning.
These revealed that the issue was upsized in both price and volume. Initial investors paid $18 per share, up from the previously anticipated $14 to $16. Just over 47.4 million shares were sold; 35 million was the original plan. Meanwhile, the IPO's underwriters fully exercised their right to buy additional shares (6.2 million, all told).
Finally, American Well said that Alphabet's (NASDAQ: GOOG)(NASDAQ: GOOGL) Google has, as agreed, bought a stake in the company for $100 million. This deal, which establishes Alphabet's Google Cloud service as the company's "preferred global cloud platform," gives the tech giant a 2.5% stake in its partner. Alphabet and American Well will also collaborate on the research and development of telemedicine tech.
In short, Amwell's IPO was successful and then some. That's not really surprising, given the understandable popularity of telemedicine stocks such as Teladoc (NYSE: TDOC) in the please-stay-at-home environment of the coronavirus pandemic. Like Teladoc, Amwell is going to be a stock to watch in this segment, particularly given its already large customer base and expansive provider network.
10 stocks we like better than American Well Corporation
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and American Well Corporation wasn't one of them! That's right -- they think these 10 stocks are even better buys.
*Stock Advisor returns as of August 1, 2020
Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Alphabet (A shares), Alphabet (C shares), and Teladoc Health. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.